Newsfeeds - Spark Newswire

1 minute read

Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation

Today, 3:49 AM

Bristol Myers Squibb & Co’s (NYSE:BMY) Eliquis, Pfizer Inc’s (NYSE:PFE) Ibrance, and AbbVie Inc’s (NYSE:ABBV) Imbruvica are expected to be among the ten…

ABBV

6 minute read

Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them

By Chris Katje

Today, 3:49 AM

Super Bowl LVII aired Sunday Feb. 12, 2023 and featured dozens of commercials advertising products and showcasing new movies and television shows. The commercials also featured many celebrity cameos and several reunions. Here’s a look at the complete list.

ALPMY

1 minute read

Analyst Says Selecta Biosciences’ Gout Candidate Can Potentially Raise The Bar On Several Fronts

By Vandana Singh

Today, 3:49 AM

Canaccord Genuity has increased the price target for Selecta Biosciences Inc (NASDAQ:SELB) from $9 to $10 while maintaining the Buy rating ahead of…

ALPMF

1 minute read

Astellas’ Menopause Drug Under FDA Review

By Vandana Singh

Today, 3:49 AM

The FDA accepted Astellas Pharma Inc’s (OTC:ALPMF) menopause treatment for approval five months after the therapy hit a speed bump in…

ALPMF

1 minute read

Sutro Biopharma Stock Surges On Cancer Treatment Pact

By Vandana Singh

Today, 3:49 AM

Astellas Pharma Inc (OTC: ALPMF) and Sutro Biopharma Inc (NASDAQ:STRO) announced a strategic collaboration and licensing agreement focused on the discovery and development of…

ALPMF

3 minute read

The Daily Biotech Pulse: CHMP Backs AstraZeneca’s Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

By Vandana Singh

Today, 3:49 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ALPMF

1 minute read

Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies

By Vandana Singh

Today, 3:49 AM

Twist Bioscience Corporation (NASDAQ:TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC:ALPMF) to conduct research…

ALPMF